Bitrobius Genetics is a developer of a DNA transfer technology designed to revolutionize gene and cancer therapy.
Bitrobius Genetics has raised $945K in total funding. The most recent round was Grant. The last funding was announced in September 2026.
Bitrobius Genetics's investors include Future Planet Capital, ARIA.
Bitrobius Genetics is headquartered in Macclesfield, United Kingdom.
Bitrobius Genetics is a developer of a DNA transfer technology designed to revolutionize gene and cancer therapy.
Bitrobius Genetics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Bitrobius Genetics — Funding & Investors." VCBacked, September 14, 2026, https://www.vcbacked.co/company/bitrobius-genetics. Accessed October 5, 2026.
VCBacked. (2026). Bitrobius Genetics — Funding & Investors. Retrieved October 5, 2026, from https://www.vcbacked.co/company/bitrobius-genetics
{{cite web |title=Bitrobius Genetics — Funding & Investors |url=https://www.vcbacked.co/company/bitrobius-genetics |website=VCBacked |access-date=October 5, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated